Pediatric and Congenital Heart Disease
The shifting price tag of pulmonary valve replacement
Damien Kenny MB, MD,
Damien Kenny MB, MD
Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, Chicago, Illinois
Search for more papers by this author Ziyad M. Hijazi MD, MPH, FSCAI,
Corresponding Author
Ziyad M. Hijazi MD, MPH, FSCAI
Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, Chicago, Illinois
Correspondence to: Ziyad M. Hijazi, MD, MPH, FSCAI; Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, Chicago, IL 60612. E-mail:
[email protected]Search for more papers by this author
Damien Kenny MB, MD,
Damien Kenny MB, MD
Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, Chicago, Illinois
Search for more papers by this author Ziyad M. Hijazi MD, MPH, FSCAI,
Corresponding Author
Ziyad M. Hijazi MD, MPH, FSCAI
Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, Chicago, Illinois
Correspondence to: Ziyad M. Hijazi, MD, MPH, FSCAI; Rush Center for Congenital and Structural Heart Disease, Rush University Medical Center, Chicago, IL 60612. E-mail:
[email protected]Search for more papers by this author
First published: 20 November 2013
No abstract is available for this article.
REFERENCES
- 1
Vergales JE,
Wanchek T,
Novicoff W, et al. Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement. Catheter Cardiovasc Interv 2013; 82: 1147–1153.
- 2
Coats L,
Sun L,
Deanfield J, et al. Right ventricular outflow tract dysfunction percutaneous pulmonary valve implantation: A cost-effective strategy for management of right ventricular outflow tract dysfunction. J Am Coll Cardiol 2006; 114(suppl 945): 239A–240A.
- 3
Gatlin SW,
Kim DW,
Mahle WT. Cost analysis of percutaneous pulmonary valve replacement. Am J Cardiol 2011; 108: 572–574.
